US obesity trends and the rise of GLP-1 drugs Obesity in the US keeps rising, contributing to health risks such as diabetes and heart disease
What does the Precision Peptide Genetic Test reveal about my treatment
Hormonal Changes : When tirzepatide is discontinued, the levels of GIP and GLP-1 decrease, potentially leading to increased appetite and cravings
Ozempic Most individuals experience weight gain after stopping both phentermine and Ozempic
Hankosky, PhD, senior director of Cardiometabolic Health, Health Economics and Outcomes Research at Eli Lilly & Company, and corresponding author of this study, confirmed for Medical News Today that the participants were taking Mounjaro as an off-label treatment for weight management at the discretion of their prescribing physician. During their study, researchers also reported that about 32% of participants who started tirzepatide had class 3 obesity with a BMI of 40 kg/m 2 or more
Inositol, particularly myo-inositol and D-chiro-inositol in a 40:1 ratio, has its own evidence base for improving insulin sensitivity and ovarian function in PCOS